BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsaouli G, Ferretti E, Bellavia D, Vacca A, Felli MP. Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression. J Immunol Res 2019;2019:5601396. [PMID: 31346528 DOI: 10.1155/2019/5601396] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Mehrpouri M. The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies. European Journal of Pharmacology 2022. [DOI: 10.1016/j.ejphar.2022.174831] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Del Gaizo M, Sergio I, Lazzari S, Cialfi S, Pelullo M, Screpanti I, Felli MP. MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia. Int J Mol Sci 2022;23:829. [PMID: 35055013 DOI: 10.3390/ijms23020829] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Bigas A, Rodriguez-Sevilla JJ, Espinosa L, Gallardo F. Recent advances in T-cell lymphoid neoplasms. Exp Hematol 2021:S0301-472X(21)00622-6. [PMID: 34879258 DOI: 10.1016/j.exphem.2021.12.191] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cordo' V, van der Zwet JCG, Canté-Barrett K, Pieters R, Meijerink JPP. T-cell Acute Lymphoblastic Leukemia: A Roadmap to Targeted Therapies. Blood Cancer Discov 2021;2:19-31. [PMID: 34661151 DOI: 10.1158/2643-3230.BCD-20-0093] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
5 Sottoriva K, Pajcini KV. Notch Signaling in the Bone Marrow Lymphopoietic Niche. Front Immunol 2021;12:723055. [PMID: 34394130 DOI: 10.3389/fimmu.2021.723055] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
6 Zhang X, Zhong L, Zou Z, Liang G, Tang Z, Li K, Tan S, Huang Y, Zhu X. Clinical and Prognostic Pan-Cancer Analysis of N6-Methyladenosine Regulators in Two Types of Hematological Malignancies: A Retrospective Study Based on TCGA and GTEx Databases. Front Oncol 2021;11:623170. [PMID: 33816257 DOI: 10.3389/fonc.2021.623170] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
7 Chittasupho C, Aonsri C, Imaram W. Targeted dendrimers for antagonizing the migration and viability of NALM-6 lymphoblastic leukemia cells. Bioorg Chem 2021;107:104601. [PMID: 33476870 DOI: 10.1016/j.bioorg.2020.104601] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 López-López S, Monsalve EM, Romero de Ávila MJ, González-Gómez J, Hernández de León N, Ruiz-Marcos F, Baladrón V, Nueda ML, García-León MJ, Screpanti I, Felli MP, Laborda J, García-Ramírez JJ, Díaz-Guerra MJM. NOTCH3 signaling is essential for NF-κB activation in TLR-activated macrophages. Sci Rep 2020;10:14839. [PMID: 32908186 DOI: 10.1038/s41598-020-71810-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
9 Lin A, Zhang H, Hu X, Chen X, Wu G, Luo P, Zhang J. Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer. Pharmacol Res. 2020;159:105028. [PMID: 32569820 DOI: 10.1016/j.phrs.2020.105028] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]